Michael J. Purcell
CIK 1694934 · last filed 2026-07-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.31M
Companies
5
Total Filings
51
Lifetime Open-Market Net
$394.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMXI | Director | 98,558 | $13.20 | $1.30M | $105.5K | 33 | 2026-07-20 |
| Hepion Pharmaceuticals, Inc. (HEPA) Delisted | Director | — | $0.08 | — | $0 | 1 | 2024-03-07 |
| Tabula Rasa HealthCare, Inc. (TRHC) Delisted | Director | 139,322 | $10.50 | $1.46M | $289.0K | 13 | 2023-06-13 |
| International Money Express, Inc. (IMXIW) Delisted | Director | 7,063 | — | — | $0 | 1 | 2018-07-30 |
| PN | Director | 1,237 | $9.04 | $11.2K | $0 | 1 | 2017-01-25 |
Recent Filings · Page 2 of 6
51 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-03 | IMXI | Grant (A) | +889 | $15.6K | EDGAR |
| 2024-07-29 | IMXI | Grant (A) | +238 | $5.0K | EDGAR |
| 2024-07-03 | IMXI | Grant (A) | +771 | $15.6K | EDGAR |
| 2024-06-26 | IMXI | Grant (A) | +7,098 | $145.0K | EDGAR |
| 2024-04-02 | IMXI | Grant (A) | +1,384 | $0 | EDGAR |
| 2024-03-07 | Hepion Pharmaceuticals, Inc. (HEPA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | IMXI | Grant (A) | +707 | $0 | EDGAR |
| 2023-11-14 | — | Disp (D) | −139,322 | $0 | |
| 2023-10-03 | IMXI | Grant (A) | +923 | $0 | EDGAR |
| 2023-07-03 | IMXI | Grant (A) | +739 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.